(+86)-400-6768632

(+49)-30-81865123

global@osmundacn.com

Home > News >

News infomation
Post-Market surveillance, personalized medical devices and Cybersecurity - IMDRF guidance documents April 2023

272023-04

MDSAP Audit approach guideline update

142023-04

Extension of CE Certificates and UK MHRA

052023-04

OSMUNDA Successfully Assisted the Enterprise in Acquiring the Approval for Urgently Needed Medical Device

242020-01

NMPA Notice: New Clinical Trial Exemption List for Medical Devices and In-vitro Diagnostic Products

302019-12

NMPA Notice: Guideline Draft on the Usage of Real-world Data in Clinical Evaluation

172019-12

Company Profile
Our services
Contact us
+49 30 5059 0627+49 30 8186 5124
email:osmunda@osmundacn.comglobal@osmundacn.com
LinkedInOsmunda
Copyright © 2023 Osmunda Medical Device Service Group              粤ICP备05082100号-3